Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence.  Ghosh A, Mahintamani T, Rana DK, Basu D, Mattoo SK.  Indian J Psychiatry. 2022 Mar-Apr;64(2):199-208. doi: 10.4103/i…

Non–prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder Williams, Arthur Robin et al. Journal of Substance Abuse Treatment, Volume 0, Issue 0, 108770  https://www.journalofsubstanceabusetreatment…

Buprenorphine for High-dose Tramadol Dependence: A Case Report of Successful Outpatient Treatment.  Mukau L, Wormley K, Tomaszewski C, Ahmad B, Vohra R, Herring AA.  Clin Pract Cases Emerg Med. 2022 Feb;6(1):71-74. doi: 10.5811/cpcem.202…

Integrating Buprenorphine Treatment for Opioid Use with Primary Care is Associated with Greater Retention in Treatment.  Mirer AG, Tiemstra JD, Hammes NE, Cloum HM, LaFavor KJ.  J Am Board Fam Med. 2022 Jan-Feb;35(1):206-208. doi: 10.312…

Experiences and Preferences of Opioid-Use-Disorder Patients Who Switched from Brand to Generic Buprenorphine/Naloxone Films: A Case Series.  Cedeño E, Cruz A, Cortés J, Melin K, Roman L, Gonzalez A, Duconge J, Santiago D.  Patient Prefer…

Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients.  Moss LM, Algera MH, Dobbins R, Gray F, Strafford…